Skip to main content
Recall Canary
Methylergonovine Maleate Tablets
← Back to all recalls
DRUG RECALLMODERATE

Methylergonovine Maleate Tablets

Major Pharmaceuticals is recalling 0.2 mg Methylergonovine Maleate Tablets due to subpotency.

What to do

Contact your healthcare provider or pharmacist to discuss alternative treatment options and return the affected medication to the place of purchase.

Posted
Updated
Recall No.
D-0609-2026
Agency
Firm
The Harvard Drug Group LLC
Recall ID
99240
Status
ONGOING

Why it was recalled

Major Pharmaceuticals is recalling Methylergonovine Maleate Tablets, 0.2 mg, due to the product being subpotent. This recall affects the 20-tablet carton configuration.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.

Recall #
D-0609-2026

Where it was sold

Distributed nationwide.

Other recent recalls from The Harvard Drug Group LLC

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-23 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification